Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
ClinicalTrials.gov study NCT06704152. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT05531786. IPD Sharing: YES. Countries: 1. Publications: 0.
Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial
ClinicalTrials.gov study NCT05686538. IPD Sharing: NO. Countries: 1. Publications: 0.
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT03986086. IPD Sharing: NO. Countries: 1. Publications: 0.
On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge
ClinicalTrials.gov study NCT06625619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
ClinicalTrials.gov study NCT00670423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov study NCT01882387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04539470. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT05005299. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06315309. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise During the Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00883714. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience
ClinicalTrials.gov study NCT05088941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transpl
ClinicalTrials.gov study NCT07249346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06265584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06643195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients
ClinicalTrials.gov study NCT03642977. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT00841724. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00068523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01541280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06809712. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.